Device
Lung Clearance Index
Lung Clearance Index is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
1
25%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)
Trials by Status
recruiting125%
completed250%
terminated125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
NCT02740868
completednot_applicable
The Utility of Lung Clearance Index in Ethnic Groups and in Disease
NCT05989360
completed
Determinants of Early Cystic Fibrosis Lung Disease
NCT03579173
terminatedearly_phase_1
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
NCT03497117
Clinical Trials (4)
Showing 4 of 4 trials
NCT02740868Phase 2
Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
NCT05989360Not Applicable
The Utility of Lung Clearance Index in Ethnic Groups and in Disease
NCT03579173
Determinants of Early Cystic Fibrosis Lung Disease
NCT03497117Early Phase 1
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4